INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M959. A total of 1 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | -100.0% | 1 | -98.3% | 0.00% | -100.0% |
| Q3 2017 | $18,000 | +1700.0% | 58 | +1060.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 5 | -58.3% | 0.00% | – |
| Q3 2016 | $1,000 | -75.0% | 12 | -45.5% | 0.00% | – |
| Q2 2016 | $4,000 | +33.3% | 22 | +83.3% | 0.00% | – |
| Q1 2016 | $3,000 | – | 12 | +500.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 2 | -60.0% | 0.00% | – |
| Q3 2015 | $1,000 | – | 5 | -58.3% | 0.00% | – |
| Q2 2015 | $0 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 54,000 | $227,000 | 0.00% |